Available in the shop
- SS-31 10 mg — $174.30
- SS-31 50 mg — $766.50
Sold for in vitro laboratory research only — not for human or animal consumption. ≥99% purity specification.
Identification
| Field of research | Anti-ageing research |
|---|---|
| Formula | C32H49N9O5 |
| Molecular weight | 639.8 g/mol |
| CAS number | 736992-21-5 |
| Also known as | bendavia, Ocuvia, MTP-131, MTP 131, SS-31, Szeto-schiller peptide, Elamipretida, MTP131, Nh2-d-arg-dmt-lys-phe-nh2, RX 31 |
| PubChem | CID 11764719 |
Summary
Elamipretide, sold under the brand name Forzinity, is a medication used for the treatment of Barth syndrome.
From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).
Published research
Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.
- Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical TrialRandomized Controlled TrialClinical Trial, Phase IIIResearch Support, Non-U.S. Gov'tKaraa A, Bertini E, Carelli V et al. · Neurology, 2023 · PMID 37268435 · DOI
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
- Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic PotentialReviewTung C, Varzideh F, Farroni E et al. · Int J Mol Sci, 2025 · PMID 39940712 · DOI
- Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in miceZhao W, Xu Z, Cao J et al. · J Neuroinflammation, 2019 · PMID 31747905 · DOI
- Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)ReviewNashine S · Cells, 2021 · PMID 34572131 · DOI
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future PerspectivesReviewRenke G, Chinellato L · Int J Mol Sci, 2026 · PMID 42123471 · DOI
- Elamipretide: First ApprovalReviewShirley M · Drugs, 2026 · PMID 41335372 · DOI
- Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trialRandomized Controlled TrialClinical Trial, Phase IIIResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tKaraa A, Bertini E, Carelli V et al. · Orphanet J Rare Dis, 2024 · PMID 39574155 · DOI
Top 8 of 206 results, by relevance. See all on PubMed.
Search query "Elamipretide"[Title/Abstract]
Data provenance
| Data | Source | Record |
|---|---|---|
| Chemical identity and structure | PubChem | CID 11764719 |
| Published literature | PubMed | Search on PubMed |
| Summary sentence | Wikipedia | Elamipretide |
Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.